These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8827420)

  • 1. Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia.
    Van Ameringen M; Mancini C; Wilson C
    J Affect Disord; 1996 Jul; 39(2):115-21. PubMed ID: 8827420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone augmentation of a selective serotonin reuptake inhibitor: efficacy in two depressed patients with comorbid anxiety and type I alcohol dependence.
    Sprenger D
    J Clin Psychopharmacol; 1997 Oct; 17(5):425-6. PubMed ID: 9315996
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder.
    Seedat S; Stein MB
    J Clin Psychiatry; 2004 Feb; 65(2):244-8. PubMed ID: 15003080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buspirone in social phobia.
    Schneier FR; Saoud JB; Campeas R; Fallon BA; Hollander E; Coplan J; Liebowitz MR
    J Clin Psychopharmacol; 1993 Aug; 13(4):251-6. PubMed ID: 8376612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study.
    van Vliet IM; den Boer JA; Westenberg HG; Pian KL
    J Clin Psychiatry; 1997 Apr; 58(4):164-8. PubMed ID: 9164427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
    Rickels K; Mangano R; Khan A
    J Clin Psychopharmacol; 2004 Oct; 24(5):488-96. PubMed ID: 15349004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine in social phobia.
    Mancini C; Ameringen MV
    J Clin Psychiatry; 1996 Nov; 57(11):519-22. PubMed ID: 8968300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of serotonin drugs in the treatment of social phobia.
    Tancer ME; Uhde TW
    J Clin Psychiatry; 1997; 58 Suppl 5():50-4. PubMed ID: 9184626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bruxism and oral parafunctional hyperactivity in social phobia outpatients.
    Hermesh H; Schapir L; Marom S; Skopski R; Barnea E; Weizman A; Winocur E
    J Oral Rehabil; 2015 Feb; 42(2):90-7. PubMed ID: 25238249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of drug therapy in social phobia.
    Lydiard RB
    J Affect Disord; 1998 Sep; 50 Suppl 1():S35-9. PubMed ID: 9851577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication augmentation after the failure of SSRIs for depression.
    Trivedi MH; Fava M; Wisniewski SR; Thase ME; Quitkin F; Warden D; Ritz L; Nierenberg AA; Lebowitz BD; Biggs MM; Luther JF; Shores-Wilson K; Rush AJ;
    N Engl J Med; 2006 Mar; 354(12):1243-52. PubMed ID: 16554526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.
    Papakostas GI; Petersen TJ; Nierenberg AA; Murakami JL; Alpert JE; Rosenbaum JF; Fava M
    J Clin Psychiatry; 2004 Feb; 65(2):217-21. PubMed ID: 15003076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression.
    Fischer P; Tauscher J; Küfferle B; Kasper S
    Int Clin Psychopharmacol; 1998 Mar; 13(2):83-6. PubMed ID: 9669189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia.
    Bouwer C; Stein DJ
    J Affect Disord; 1998 Apr; 49(1):79-82. PubMed ID: 9574863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buspirone potentiation of antidepressants in the treatment of PTSD.
    Hamner M; Ulmer H; Horne D
    Depress Anxiety; 1997; 5(3):137-9. PubMed ID: 9323455
    [No Abstract]   [Full Text] [Related]  

  • 18. Buspirone augmentation of antidepressant therapy.
    Dimitriou EC; Dimitriou CE
    J Clin Psychopharmacol; 1998 Dec; 18(6):465-9. PubMed ID: 9864079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buspirone is an effective augmenting agent of serotonin selective re-uptake inhibitors in severe treatment-refractory depression.
    Bouwer C; Stein DJ
    S Afr Med J; 1997 Apr; 87(4 Suppl):534-7, 540. PubMed ID: 9180827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin syndrome after sertraline, buspirone and loxapine?
    Bonin B; Vandel P; Vandel S; Sechter D; Bizouard P
    Therapie; 1999; 54(2):269-71. PubMed ID: 10394270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.